Answer
Patients with diabetes starting glecaprevir + pibrentasvir may experience improved glucose control after initiating HCV direct acting antiviral treatment, potentially resulting in symptomatic hypoglycaemia.
Sources for this answer
- Glecaprevir/Pibrentasvir 100 mg/40 mg film-coated tabletsAbbVie Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 24Document updated
Sources checked